MalDA Members

The Malaria Drug Accelerator (MalDA) is a consortium of 18 leading scientific laboratories, founded to advance the development of antimalarial drugs.

Bill & Melinda Gates Foundation

Dr. Gang Liu
Senior Program Officer, Discovery & Translational Sciences

Winzeler Lab at the University of California, San Diego

Dr. Elizabeth A. Winzeler
Program Director

Medicines for Malaria Venture (MMV)

Dr. Brice Campo
Senior Director Drug Discovery

Wirth Lab at Harvard T.H. Chan School of Public Health

Dr. Dyann F. Wirth
Director

Fidock Lab at Columbia University Irving Medical Center

Dr. David Fidock
Director

Goldberg Lab at Washington University

Dr. Daniel Goldberg
Director, Infectious Diseases

GlaxoSmithKline

Dr. Javier Gamo
Director

Lee Lab at Wellcome Sanger Institute

Dr. Marcus Lee
Group Leader

Niles Lab at Massachusetts Institute of Technology

Prof. Jacquin C. Niles
Principal Investigator

The Global Health Drug Discovery Institute

Dr. Nobutaka Kato
Malaria Disease Biology, PI

Wellcome Centre for Anti-Infectives Research (WCAIR), at the University of Dundee

Prof. Ian Gilbert
Head of Chemistry in the Drug Discovery Unit

Llinas Lab at Pennsylvania State University

Prof. Manuel Llinás
Principal Investigator

Holistic Drug Discovery and Development (H3D) Centre, University of Cape Town

Prof. Kelly Chibale
Director of H3D

TropIQ Health Sciences

Dr. Koen Dechering
Director

Calibr-Skaggs Institute for Innovative Medicines

Dr. Case McNamara
Director, Infectious Disease

Lgenia

Dr. Philip Hipskind
Director of Lgenia

Novartis Institutes for Biomedical Research

Dr. Thierry Diagana
Head of the Novartis Institute for Tropical Diseases